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STRUCTURED ABSTRACT  
Background  
Obstetric early warning systems are recommended for monitoring hospitalised pregnant and postnatal 
women. We decided to compare (i) vital sign values used to define physiological normality (ii) 
symptoms and signs used to escalate care, (iii) type of chart used, and (iv) presence of explicit 
instructions for escalating care. 
 
Methods 
One hundred and twenty obstetric early warning charts and escalation protocols were obtained from 
consultant-led maternity units in United Kingdom and Channel Islands. These data were extracted: 
values used to determine normality for each maternal vital sign; chart colour-coding; instructions 
following early warning system triggering; other criteria used as triggers. 
 
Results  
There was considerable variation in the charts, warning systems and escalation protocols. Of 120 
charts, 89.2% used colour; 69.2% used colour-coded escalation systems. Forty-one (34.2%) systems 
required the calculation of weighted scores. Seventy-five discrete combinations of ‘normal’ vital sign 
ranges were found, the most common being: heart rate = 50-99; respiratory rate = 11-20; blood 
pressure, systolic = 100-149mmHg, diastolic = <89mmHg; SpO2 = 95-100%; temperature = 36.0-
37.9oC; and AVPU assessment = Alert. Most charts (90.8%) provided instructions about who to 
contact following triggering, but only 41.7% gave instructions about subsequent observation 
frequency.  
 
Conclusions  
The wide range of ‘normal’ vital sign values in different systems suggests a lack of equity in the 
processes for detecting deterioration and escalating care in hospitalised pregnant and postnatal 
women. Agreement regarding ‘normal’ vital sign ranges is urgently required and would assist the 
development of a standardised obstetric early warning system and chart. 
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INTRODUCTION 
Early warning systems are recommended for monitoring the condition of hospitalised pregnant and 
postnatal women, to facilitate the early detection and management of clinical deterioration.1-6 Some 
maternity units use systems designed primarily for the non-pregnant population.7 Others employ 
obstetric-specific systems comprising ‘calling criteria’ based on maternal vital sign measurements, 
symptoms and clinical signs, and conditions that commonly cause maternal morbidity and mortality.8-
10 The regular measurement of a woman’s vital signs is a universal feature of obstetric early warning 
systems (ObsEWS) and choosing the correct normal ranges for measured variables is fundamental to 
their appropriate, safe and efficient use.11 However, publications suggest that ObsEWS vary with 
respect to the included vital signs and the physiological values used to reflect normality.1-10  
 
Several types of ObsEWS exist. Some trigger a clinical response by a midwife, obstetrician or rapid 
response team,12 when one or more abnormal observations are identified.3 Others trigger the same 
response when one or more markedly abnormal, or two or more mildly abnormal, observations are 
present.13,14 These systems are frequently used alongside charts featuring colour-coded shading to 
highlight the markedly and mildly abnormal vital signs ranges, often shaded in red and yellow, 
respectively (Figure 1).1, 15 A third type of ObsEWS allocates points in a weighted manner, based on 
the derangement of a woman’s measured vital signs from pre-defined ‘normal’ ranges (Table 1).16,17 
The sum of these points, known as the early warning score (EWS), is used to direct subsequent care. 
Some hospitals use combinations of the three systems. 
 
We decided to analyse early warning charts in routine use in consultant-led maternity units in the UK 
and Channel Islands to establish the vital sign values used to determine normality in ObsEWS. We 
also identified other items used as triggers for escalating care (e.g., maternal symptoms, clinical signs 
and conditions), the type of vital signs chart used and the presence of explicit instructions for 
escalating care. 
 
 
METHODS 
We wrote to all lead consultant anaesthetists registered with the Obstetric Anaesthetists’ Association 
(OAA) to request participation in an analysis of obstetric early warning charts, ObsEWS and 
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associated escalation protocols used in consultant-led maternity units in the UK and Channel Islands. 
Contact details were provided by the OAA. We requested a copy of the vital signs/ObsEWS chart and 
associated escalation protocol used in each unit. Invitees were asked to send these by email or mail 
(a stamped-addressed envelope was provided). Invitees were assured that all data would remain 
confidential, and no hospital identifiers would be revealed during presentations or publications arising 
from the study.  The study extended two earlier OAA-approved surveys (Nos 76 & 135) into UK 
ObsEWS and escalation policies, undertaken by members of our group.8,9  
 
Non-responding leads/units were contacted again via telephone, follow-up letter and email. All were 
contacted a minimum of seven times (one telephone call, three letters and three emails). All 
documentation received by the study group was scanned, given a unique hospital identifier (No 1-194) 
and uploaded to a secure database for analysis. 
 
Analysis 
Two members of the research team (GS and RI) analysed each chart individually, and created a 
spreadsheet containing the amalgamated data. Where opinions differed the charts were re-checked 
to establish a single result for each data item.  
 
We documented whether each obstetric early warning chart was colour-coded, and if the chart 
identified: (i) who to call upon ObsEWS triggering; and (ii) the frequency of vital signs monitoring 
expected after activation. We identified the items used as triggers for escalation (i.e., vital signs, 
maternal symptoms, clinical signs, and conditions) from the chart alone, or, where necessary, from 
the chart and the associated EWS. For each maternal vital sign parameter studied (i.e., respiratory 
rate (RR), heart rate (HR), systolic blood pressure (sBP), diastolic blood pressure (dBP), mean blood 
pressure (mBP), temperature (T), AVPU (Alert-Voice-Pain-Unresponsive) and SpO2), we noted (a) 
whether it was used as a component of the ObsEWS, and (b) the values used to determine 
physiological normality on the vital signs chart or, if used, in the EWS. Similarly, we did the same for 
Glasgow Coma Score (GCS), maternal urine output and maternal oxygen administration. In addition, 
we noted whether other observations, criteria or abnormalities (e.g., presence of maternal proteinuria; 
uterine tone; maternal pain) were used as triggers in the early warning system. 
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Research Ethics 
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RESULTS 
A total of 194 lead obstetric anaesthetists were invited to contribute obstetric early warning charts and 
escalation protocols from their unit(s). Charts were returned by 127 (65.5%) but seven (3.6%) were 
unusable (e.g., poor quality photocopy, black and white photocopy where colour-coding was used). Of 
the 120 charts available for analysis, 88 were from England; 15 from Scotland; 11 from Wales; 5 from 
Northern Ireland and 1 from the Channel Islands. 
 
Type of chart and escalation system 
There was considerable variation in the design of obstetric early warning charts. Of the 120 usable 
charts, 107/120 (89.2%) used colour in some way, but only 83/120 (69.2%) used a colour-coded 
escalation system. Two different systems were used to escalate care to more experienced staff, or to 
advise subsequent clinical actions. A colour-coded triggering system similar to that developed in 
Scotland and described in the 2007 Confidential Enquiry into Maternal and Child Health (CEMACH) 
report,1 was used in 79/120 (65.8%) (Figure 1). A system that required staff to calculate an EWS from 
an aggregate weighted system was used in 41/120 (34.2%). Where a colour-coded system based on 
the presence of one or more abnormal observations (red/yellow) was used (n=79), all except one 
(triggering score not stated) escalated care in the presence of either two yellow vital signs values or 
one red value. Where an aggregate weighted EWS was used to escalate care (n=41), the lowest 
aggregate score that triggered a bedside assessment by a doctor was 2 (4/41), 3 (15/41) 4 (15/41), 5 
(4/41) and 6 (3/41).  
 
Vital signs and other parameters used in ObsEWS 
Table 2 shows the aggregated data for the vital signs and related measurements used as a 
component of the trigger system - specifically, number of discrete ‘normal’ ranges in use across the 
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units surveyed for each individual vital sign; lowest and highest value in any ‘normal’ range; most 
commonly used ‘normal’ range; number of charts using the most commonly used ‘normal’ range; and 
whether the parameter was (i) used as a component of the triggering system, (ii) recorded but not 
used in the triggering system, or (iii) not recorded nor used.  
 
The variation in vital signs ranges used to define ‘normality’ for each of: HR, RR, sBP, dBP, SpO2 and 
T are shown in Supplementary Figures 1-6. For HR, RR, sBP and SpO2, the most commonly chosen 
‘normal’ range was used in only ~50% units (Table 2). The most commonly used combination of 
‘normal’ ranges was that described in the CEMACH report1 [HR, 50-99 bpm; RR, 11-20 bpm; sBP, 
100-149 mmHg; dBP, <89 mmHg; SpO2, 95-100%; T, 36.0-37.9oC; and AVPU, A], however, this was 
used in only 16/120 (13.3%) units. Of the 120 charts assessed, 102 (85%) included all seven vital 
signs that appear on the CEMACH chart (i.e., HR; RR; sBP; dBP; SpO2; T; AVPU). However, there 
were 75 discrete combinations of ‘normal’ ranges in use for these seven vital sign sets. We could find 
no evidence that any unit used a different ObsEWS for different stages of pregnancy or in the 
postpartum period.  
 
Table 3 shows the range of maternal symptoms and signs, and other clinical observations or 
measurements used as components of the ObsEWS reviewed. Whilst many of these supplementary 
observations formed part of a colour-coded chart and triggering system, some of these items 
contributed weightings to an aggregate EWS value. 
 
Escalation instructions 
The baseline frequency for recording vital signs was not always recorded on the ObsEWS charts. 
Where recorded, it varied between units and was usually every 12 hours or more frequent. Only 
50/120 (41.7%) provided instructions about changes in the vital sign measurement frequency once 
vital sign abnormalities were identified. In these circumstances, the subsequent vital signs 
measurement frequency was increased to a variable extent, usually to every 15-30 minutes. Usually, 
the frequency was determined by the degree of physiological derangement observed. Most charts 
(109/120; 90.8%) provided instructions about who to contact once the ObsEWS had triggered. 
 
 
  
8 
DISCUSSION 
We found a lack of agreement amongst the ObsEWS employed in consultant-led maternity units in 
the UK and Channel Islands regarding the most appropriate vital sign parameters to measure and the 
vital sign values regarded as ‘normal’ values for each parameter.  These disparities probably exist 
because there is a paucity of knowledge regarding which vital signs, or combination of vital signs, are 
predictive of maternal deterioration during and after pregnancy, and this makes it difficult to obtain 
agreement on the necessary appropriate vital signs to measure routinely or to include in an ObsEWS. 
Similarly, although it is known that pregnancy alters maternal physiology,18 data are lacking regarding 
the normal maternal vital sign ranges for each stage of pregnancy, labour and the post-partum 
period.11  
 
The uncertainties arising from these knowledge gaps result in potential conflicts in maternal care. The 
vital sign normal ranges in several ObsEWS studied lie outside the recently published reference 
ranges in healthy term pregnant women undergoing caesarean section.19 More than 20% units which 
include SpO2 in their ObsEWS use an SpO2 ‘normal’ range with a lower limit below 94%, i.e., below the 
British Thoracic Society recommended lower limit for target SpO2 during pregnancy.20 The normal 
ranges used for some parameters overlap with those used to highlight possible sepsis,21-23 which is 
especially concerning as sepsis is a significant direct cause of maternal mortality and morbidity.24 
There are also examples of blood pressure ‘normal’ ranges overlapping with those used by the 
National Institute for Health and Care Excellence to define mild diastolic and severe systolic 
hypertension in pregnancy.25 In addition, the parameters and normal values used in units in the UK 
and Channel Islands are also different to those being used in iMEWS in Ireland2 and in the Maternal 
Early Warning Criteria recommended in the USA.3 Data collection to establish a set of ‘normal’ vital 
signs ranges for pregnancy is currently underway11 and may lead to the resolution of some of these 
uncertainties and disparities.  
 
The determination of a set of ‘normal’ vital signs ranges for pregnancy would facilitate the 
development of a single validated ObsEWS for the UK and Channel Islands, although a particular 
challenge will be the identification of suitable clinical outcomes against which the ObsEWS can be 
validated. It would also be important to identify whether it is necessary or feasible to introduce a 
different ObsEWS for each phase of pregnancy. Introducing a different ObsEWS for each phase 
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might be impractical since introducing just a single standardised ObsEWS can be challenging. 26,27 
 
There was also variation in the ObsEWS and the vital signs charts used in the 120 units. Most units 
use a chart similar to that in the CEMACH report of 2007, employing a two-colour triggering system, 
but in many units the chart has been modified. The remainder used an aggregate weighted triggering 
system requiring the calculation of an EWS. There was also variation concerning when and how to 
escalate care. Currently two-thirds of units use an ObsEWS that triggers when one or more markedly 
abnormal (red), or two or more mildly abnormal (yellow), observations occur. Superficially, these 
systems appear different to those based on aggregate weighted scoring systems. However, they can 
be considered aggregate weighted scoring systems with a triggering value of 2 (if red observations 
score 2 points & yellow score 1). Therefore, the issues that require resolution are (i) agreement on the 
range of weightings (i.e., 0-2 or 0-3), and (ii) the aggregate EWS at which care escalation occurs. 
These questions can only be answered following the collection and analysis of one or more large 
databases of maternal observations and outcomes. The design of a suitable ObsEWS chart is beyond 
the scope of our article. 
 
The 2007 CEMACH report indicated that there was “…an urgent need for the routine use of a national 
obstetric early warning chart, similar to those in use in other areas of clinical practice…” and 
suggested an auditable standard for such a chart to be developed and piloting started by the end of 
2008.1 The 2011 publication by the Maternal Critical Care Working Group4 also recommended the 
introduction of a standard early warning system and chart for obstetrics. These guidelines are 
currently being updated and are expected to recommend the use of a standard ObsEWS 
incorporating six physiological parameters - respiratory rate, SpO2, temperature, systolic BP, diastolic 
BP, and pulse rate.28 These parameters would seem to have face validity because they are almost 
identical to those previously recommended by anaesthetists9 and midwives.10  
 
There is evidence that the majority of UK obstetric anaesthetists support the need for a standardised, 
validated tool to prompt midwives and medical staff to summon help.8,9 The benefits of standardising 
aspects of healthcare include reduced staff confusion and misunderstanding, consistency in clinical 
decision-making, reduced error rate, improved reliability, transferability across organisations and the 
opportunity for uniform staff training.29 Despite this and the validation of the CEMACH chart in 2012,13 
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there has been little progress in getting universal agreement on systems for detecting maternal 
deterioration in UK obstetric population. This may be because standardised systems are often 
perceived as a challenge to professional autonomy and jurisdiction.26 Midwives may be reluctant to 
adopt ObsEWS, because they can see no inherent value.10,27 Midwives also felt that clinical 
judgement was superior to the ObsEWS and that informing a doctor when the ObsEWS 
recommended escalation was unnecessary, if the midwife believed that the woman was well.27 We 
found no evidence that maternal concern about their perceptions of being at risk was included as a 
formal component of any ObsEWS triggering system.30 
 
The study has several strengths and weaknesses. It is the largest and most detailed study of 
ObsEWS to date. Two researchers used a common, objective, systematic approach to interrogate the 
early warning system charts independently, and the analysis was not subject to influence by 
participating centres. The assistance of the contributing units contacted was essential. However, 
despite trying to contact leads/units multiple times, only 65.5% of contacted units provided charts and 
a few were unusable. In addition, not all maternity units in the UK and Channel Islands are 
represented in the OAA database. Consequently, our data may be subject to non-response and 
volunteer bias, implying that the results may not necessarily reflect the actual use of ObsEWS in other 
centres. Nevertheless, the findings of variation in the design, type and structure of vital signs charts, 
ObsEWS and escalation systems in the units studied would be unchanged (other than in magnitude) 
by data from additional units. 
 
 
SUMMARY 
There is a lack of consensus regarding the vital sign values used to reflect physiological normality in 
ObsEWS used in consultant-led UK and Channel Island maternity units. Improving agreement would 
facilitate the introduction of a standardised national obstetric early warning chart, ObsEWS and 
escalation system, but this requires further research. Standardisation would improve the equality of 
maternal care across units. 
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LEGENDS FOR FIGURES and TABLES: 
 
Figure 1: Obstetric early warning chart described in the CEMACH report of 2007. Reproduced with 
permission of Dr.F Mcilveney, Forth Valley Royal Hospital. 
 
Table 1: A typical obstetric early warning score 
 
Table 2: Vital signs and other related measurements used to trigger early warning system escalation. 
 
Table 3: Maternal symptoms and signs, and other clinical observations or measurements used as a 
component of obstetric early warning systems.  
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Table 1 1 
 2 
 3 2 1 0 1 2 3 
Breathing rate (bpm) <10   10-14 15-20 21-30 >30 
SpO2 (%) <94   >94    
Temperature (oC)  <35.0 35.0–35.9 36.0-38.0  >38.0  
Systolic blood pressure (mmHg) <80 80-90 91-100 101-140 141-150 151-159 >160 
Diastolic blood pressure (mmHg)    <90 91-100 101-110 >110 
Heart rate (bpm) <40 41-50 51-60 61-100 101-110 111-130 >130 
Level of consciousness    Alert Responds to 
Voice 
Responds to 
Pain 
Unconscious 
 3 
4 
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Table 2:  5 
 6 
 HR 
(beats 
per 
minute) 
RR 
(breaths 
per 
minute) 
sBP 
(mmHg) 
dBP 
(mmHg) 
mBP 
(mmHg) 
SpO2 
(%) 
T 
(oC) 
AVPU Use of O2 Urine 
Output 
(mls per hr.) 
GCS 
Number of discrete 
‘normal’ ranges in use 
across the units surveyed 
for each individual vital 
sign. 
16 14 21 15 2 12 7 2 - - - 
Lowest value used in any 
‘normal’ range 40 8 80 40 0 90 35.0 A or V - - - 
Highest value used in any 
‘normal’ range 109 20 199 100 <124 100 38.0 A - - - 
Most commonly used 
‘normal’ range 50-99 11-20 100-149 <89 <124 95-100 36.0-37.9 A - >30 - 
No. (%) using most 
common range 
62/120 
(51.7%) 
64/120 
(53.3%) 
59/120 
(49.2%) 
88/117 
(75.2%) 
6/7 
(85.7%) 
59/112 
(52.7%) 
74/119 
(62.2%) 
109/112 
(97.3%) - 
13/48 
(27.1%) 
1/1 
(100%) 
Used as a component of 
the escalation system 
120/120 
(100%) 
120/120 
(100%) 
120/120 
(100%) 
117/120 
(97.5%) 
7/120 
(5.8%) 
112/120 
(93.3%) 
119/120 
(99.2%) 
112/120 
(93.3%) 
8/120 
(6.6%) 
48/120 
(40.0%) 
1/120 
(0.8%) 
Recorded but not used 0/120 (0%) 
0/120 
(0%) 
0/120 
(0%) 
0/120 
(0%) 
14/120 
(11.7%) 
7/120 
(5.8%) 
1/120 
(0.8%) 
0/120 
(0%) 
101/120 
(84.2%) 
55/120 
(45.8%) 
0/120 
(0%) 
Not recorded or used 0/120 (0%) 
0/120 
(0%) 
0/120 
(0%) 
3/120 
(2.5%) 
99/120 
(82.5%) 
1/120 
(0.8%) 
0/120 
(0%) 
8/120 
(6.7%) 
11/120 
(9.2%) 
17/120 
(14.2%) 
119/120 
(99.2%) 
 7 
HR, heart rate; RR, respiratory rate; sBP, systolic blood pressure; dBP, diastolic blood pressure; mBP, mean blood pressure; T, temperature;  AVPU, (Alert-Voice-8 
Pain-Unresponsive); GCS, Glasgow Coma Scale. 9 
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Table 3:  11 
 Recorded on vital 
signs charts and 
used as component 
of triggering system 
 [n, (%)] 
Recorded on vital 
signs charts, but 
not used as 
component of 
triggering system 
[n, (%)] 
Not recorded on 
vital signs charts 
nor used as 
component of 
triggering system 
[n, (%)] 
Used as a 
component of 
aggregate EWS 
 
[n, (%)] 
Maternal pain score 76 (63.3%) 24 (20.0%) 20 (16.7%) 3 (2.5) 
Characteristics of lochia 68 (56.7%) 9 (7.5%) 43 (35.8%) 0 
Proteinuria 65 (54.2) 12 (10.0) 43 (35.8) 7 (5.8) 
Mother looks unwell 63 (52.5%) - 57 (47.5%) 2 (1.7) 
Characteristics of amniotic fluid 47 (39.2%) 5 (4.2%) 68 (56.7%) 1 (0.8) 
Presence of nausea 13 (10.8%) 25 (20.8%) 82 (68.3%) 0 
Drains/blood loss 12 (10.0) 7 (5.8%) 101 (84.2%) 1 (0.8) 
Uterine tone 11 (9.2%) 6 (5.0%) 103 (85.8%) 0 
Sedation level 3 (2.5%) 12 (10.0) 105 (87.5%) 1 (0.8) 
Briskness of maternal neuroreflexes 3 (2.5%) 7 (5.8%) 110 (91.7%) 0 
Level of epidural-related motor block 3 (2.5) 5 (4.2) 112 (93.3) 0 
Level of epidural-related sensory block 2 (1.7%) 6 (5.0) 112 (93.3) 0 
Maternal blood glucose level 2 (1.7%) 18 (15.0) 100 (83.3) 0 
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